查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1425011

抗逆轉錄病毒藥物市場，按產品類型、按應用、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Anti-retroviral Drugs Market, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 291 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022年抗愛滋病毒藥物市場規模為397.942億美元，2023年至2030年複合CAGR為5.1%。

抗逆轉錄病毒藥物市場-市場動態

愛滋病毒負擔的增加，研發投資的增加以及更有效的新藥的出現預計將推動市場需求

分析市場的成長受到幾個關鍵因素的推動，包括愛滋病毒負擔的增加，研發（R&D）投資的增加以及更有效的新藥的出現。例如，2022年，印度愛滋病毒估計情況說明書報告指出，2021年每年新增感染病例（ANI）估計為62970 例。此外，世界衛生組織（WHO）於2022年7月報告指出，印度有3840 萬人感染愛滋病毒。2021年。非洲地區仍受到嚴重影響，大約每 25 名成年人中就有 1 人（3.4%）感染愛滋病毒，佔全球愛滋病毒感染人口的三分之二以上。世衛組織也強調，過去20年來，愛滋病毒病例顯著增加了 32.8%。因此，愛滋病毒流行率的不斷上升刺激了對抗逆轉錄病毒藥物的需求。

此外，各製藥公司加大研發投入是市場成長的動力。例如，2022年 6月，GSK（GlaxoSmithKline）宣布巨額投資 10 億歐元，目的是加速治療傳染病的研發活動，特別是那些對低收入國家影響尤為嚴重的傳染病。 GSK 的研究重點是開發新型創新疫苗和藥物，以預防和治療各種疾病，包括愛滋病毒（透過 ViiV Healthcare）、瘧疾、結核病和其他傳染病。這些疾病總共佔許多低收入國家疾病負擔的 60%以上。 GSK 的全球健康研發中心推動 30 多種潛在的新疫苗和藥物，針對 13 種高負擔傳染病，包括抗逆轉錄病毒藥物研究。因此，增加研發投資是研究市場擴張的重要促進因素。

抗逆轉錄病毒藥物市場-關鍵見解

根據研究分析師的分析，預計全球抗逆轉錄病毒藥物市場在預測期內（2023-2030）每年將以 5.1%左右的CAGR成長

由於愛滋病毒負擔的增加、研發（R&D）投資的增加以及更有效的新藥的出現，抗逆轉錄病毒藥物市場預計將以顯著的速度成長

根據產品類型，核苷逆轉錄酶抑制劑（NRTI）和非核苷逆轉錄酶抑制劑（NNRTI）預計在2022年佔據最大市場佔有率

根據應用情況，愛滋病毒/愛滋病是2022年的主要細分市場

依地區分類，北美是2022年的主要收入來源

抗逆轉錄病毒藥物市場-細分分析：

全球抗逆轉錄病毒藥物市場根據產品類型、依應用和地區進行細分。

根據產品類型，市場分為四個部分：蛋白酶抑制劑、非核苷逆轉錄酶抑制劑、整合酶抑制劑、核苷類似物和核苷逆轉錄酶抑制劑。在此分類中，核苷逆轉錄酶抑制劑（NRTI）和非核苷逆轉錄酶抑制劑（NNRTI）脫穎而出，為該細分市場提供了巨大的成長潛力。 NRTI 透過阻斷逆轉錄酶發揮作用，而 NNRTI 則與逆轉錄酶結合併隨後修飾逆轉錄酶。這種雙重機制干擾了愛滋病毒自我複製所需的酶，使得這兩種類型在對抗病毒方面特別有效。

此市場依應用分為四個部分：肝炎、愛滋病毒/愛滋病、皰疹、流感和其他。值得注意的是，抗愛滋病毒藥物廣泛用於治療愛滋病毒/愛滋病，這主要是由於這種疾病在全球範圍內的廣泛流行。根據美國衛生與公眾服務部的報告，全世界約有 3,720 萬人與愛滋病毒/愛滋病作鬥爭。

抗逆轉錄病毒藥物市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲地區。這些區域根據開展業務的國家進一步分類。

抗愛滋病毒藥物市場-競爭格局：

在抗愛滋病毒藥物領域，公司主要致力於研究、開發和商業化。他們致力於發現和生產新的抗逆轉錄病毒療法，改進現有藥物，並進行臨床試驗以評估這些藥物的安全性和有效性。此外，製藥公司經常與醫療保健組織和政府機構合作，以擴大受影響地區獲得抗病毒治療的機會。

最近的發展：

2022年9月，Merck宣布啟動一項新的3期臨床試驗，以評估每日一次口服islatravir治療HIV-1感染的療效。

2022年 8月，Gilead的 Sunlenca（Lenacapavir）獲得了全球監管機構的批准，這是一種獨特的每年兩次的 HIV 治療選擇。

目錄

第1章 抗愛滋病毒藥物市場概述

  • 研究範圍
  • 市場預估年份

第2章 執行摘要

  • 市場摘要
    • 依產品類型分類的抗愛滋病毒藥物市場摘要
    • 依應用分類的抗愛滋病毒藥物市場摘要
    • 依國家分類的抗逆轉錄病毒藥物市場摘要
    • 依地區分類的抗愛滋病毒藥物市場摘要
  • 競爭洞察

第3章 抗愛滋病毒藥物主要市場趨勢

  • 抗逆轉錄病毒藥物市場促進因素
    • 市場促進因素的影響分析
  • 抗愛滋病毒藥物市場限制
    • 市場限制影響分析
  • 抗愛滋病毒藥物市場機會
  • 抗愛滋病毒藥物市場未來趨勢

第4章 抗愛滋病毒藥物產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章 抗愛滋病毒藥物市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第6章 抗愛滋病毒藥物市場格局

  • 2022年抗愛滋病毒藥物市場佔有率分析
  • 細分資料：按主要製造商
    • 既有參與者分析
    • 新興參與者分析

第7章 抗愛滋病毒藥物市場 - 依產品類型

  • 概述
    • 依產品類型分類的細分市場佔有率分析
    • 蛋白酶抑制劑
    • 非核苷逆轉錄酶抑制劑
    • 整合酶抑制劑
    • 核苷類似物和核苷逆轉錄酶抑制劑

第8章 抗愛滋病毒藥物市場 -依應用

  • 概述
    • 依應用的細分市場佔有率分析
    • 肝炎
    • HIV愛滋病
    • 皰疹
    • 流感
    • 其他

第9章 抗愛滋病毒藥物市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美抗愛滋病毒藥物主要製造商
    • 北美市場規模和預測（依國家）
    • 北美市場規模和預測（依產品類型）
    • 北美市場規模和預測（依應用）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲抗愛滋病毒藥物主要製造商
    • 歐洲市場規模和預測（依國家）
    • 歐洲市場規模和預測（依產品類型）
    • 歐洲市場規模和預測（依應用）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區（APAC）
    • 概述
    • 亞太地區抗愛滋病毒藥物主要製造商
    • 亞太地區市場規模與預測（依國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（依應用）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲抗愛滋病毒藥物主要製造商
    • 拉丁美洲市場規模與預測（依國家）
    • 拉丁美洲市場規模與預測（依產品類型）
    • 拉丁美洲市場規模與預測（依應用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲抗逆轉錄病毒藥物主要製造商
    • 中東和非洲市場規模及預測（依國家）
    • 中東和非洲市場規模及預測（依產品類型）
    • 中東和非洲市場規模及預測（依應用）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA的其他地區

第10章 主要供應商分析-抗逆轉錄病毒藥物產業

  • 競爭儀表板
  • 公司簡介
    • AbbVie Inc.
    • Boehringer Ingelheim International GmbH
    • Bristol-Myers Squibb Company
    • F. Hoffmann-La Roche Ltd
    • Gilead Sciences, Inc.
    • Merck & Co, Inc.
    • Viatris Inc.（Mylan Inc.）
    • GlaxoSmithKline plc（ViiV Healthcare）
    • Cipla Inc.
    • Johnson and Johnson

第11章 360 度分析師視角

第12章 附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2211

REPORT HIGHLIGHT

Anti-retroviral Drugs Market size was valued at USD 39,794.2 Million in 2022, expanding at a CAGR of 5.1% from 2023 to 2030.

Antiretroviral drugs are medications used to treat retroviral infections, with HIV (Human Immunodeficiency Virus) being the most prominent example. These drugs work by inhibiting the replication of the virus, thereby slowing down the progression of the disease and reducing the viral load in the body.

Anti-retroviral Drugs Market- Market Dynamics

The increasing burden of HIV, heightened investments in research and development (R&D), and the availability of more effective novel drugs is expected to propel the market demand

The growth of the analyzed market is propelled by several key factors, including the increasing burden of HIV, heightened investments in research and development (R&D), and the availability of more effective novel drugs. For example, in 2022, the HIV Estimates Factsheet for India reported an estimated annual new infection (ANI) of 62.97 thousand cases in 2021. Furthermore, the World Health Organization (WHO) reported in July 2022 that 38.4 million individuals were living with HIV in 2021. The African region, in particular, remains profoundly impacted, with approximately 1 in every 25 adults (3.4%) living with HIV and contributing to over two-thirds of the global HIV-infected population. WHO also highlighted a significant 32.8% increase in HIV cases over the past two decades. Consequently, the growing prevalence of HIV is fueling the demand for antiretroviral drugs.

Moreover, increased investments in R&D by various pharmaceutical companies are a driving force behind the market's growth. As an illustration, in June 2022, GSK (GlaxoSmithKline) announced a substantial EUR 1 billion investment aimed at accelerating R&D activities for the treatment of infectious diseases, particularly those disproportionately affecting lower-income countries. GSK's research endeavors focus on the development of new and innovative vaccines and medications to prevent and treat various diseases, including HIV (via ViiV Healthcare), malaria, tuberculosis, and other infectious diseases. These diseases collectively account for over 60% of the disease burden in many lower-income nations. GSK's Global Health R&D Hubs are advancing with over 30 potential new vaccines and medications, targeting 13 high-burden infectious diseases, including antiretroviral drug research. Consequently, the augmented R&D investments are a significant driving factor behind the expansion of the studied market.

Anti-retroviral Drugs Market- Key Insights

As per the analysis shared by our research analyst, the global Anti-retroviral Drugs Market is estimated to grow annually at a CAGR of around 5.1% over the forecast period (2023-2030)

The Anti-retroviral Drugs Market is projected to grow at a significant rate driven by the increasing burden of HIV, heightened investments in research and development (R&D), and the availability of more effective novel drugs

Based on product type, the Nucleoside Reverse Transcriptase Inhibitors (NRTIs) and Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) was predicted to show maximum market share in the year 2022

Based on Application, HIV/AIDS was the leading Segment in 2022

On the basis of region, North America was the leading revenue generator in 2022

Anti-retroviral Drugs Market- Segmentation Analysis:

The Global Anti-retroviral Drugs Market is segmented on the basis of Product Type, By Application, and Region.

Based on the type of product, the market is divided into four segments: Protease Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors, Integrase Inhibitors, and Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors. Within this classification, Nucleoside Reverse Transcriptase Inhibitors (NRTIs) and Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) stand out prominently, offering significant growth potential to this segment. NRTIs function by blocking reverse transcriptase, while NNRTIs bind to and subsequently modify reverse transcriptase. This dual mechanism interferes with the enzyme HIV requires to replicate itself, rendering these two types particularly effective in combating the virus.

The market is categorized by application into four segments: Hepatitis, HIV/AIDS, Herpes, Influenza, and Others. Notably, anti-retroviral drugs find extensive usage in the treatment of HIV/AIDS, primarily due to the substantial global prevalence of this disease. According to reports from the US Department of Health & Human Services, approximately 37.2 million individuals worldwide are grappling with HIV/AIDS.

Anti-retroviral Drugs Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Anti-retroviral Drugs Market- Competitive Landscape:

In the field of antiretroviral drugs, companies are primarily focused on research, development, and commercialization. They work on discovering and producing new antiretroviral therapies, improving existing medications, and conducting clinical trials to assess the safety and efficacy of these drugs. Additionally, pharmaceutical companies often collaborate with healthcare organizations and government agencies to expand access to antiretroviral treatments in affected regions.

Recent Developments:

In September 2022, Merck announced the commencement of a new phase 3 clinical trial to assess the efficacy of once-daily oral islatravir for the treatment of HIV-1 infection.

In August 2022, Gilead obtained global regulatory approval for Sunlenca (Lenacapavir), a unique twice-yearly treatment option for HIV.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTI-RETROVIRAL DRUGS MARKET KEY PLAYERS

  • AbbVie Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd
  • Gilead Sciences, Inc.
  • Merck & Co, Inc.
  • Viatris Inc. (Mylan Inc.)
  • GlaxoSmithKline plc (ViiV Healthcare)
  • Cipla Inc.
  • Johnson and Johnson

GLOBAL ANTI-RETROVIRAL DRUGS MARKET, BY PRODUCT TYPE

  • Protease Inhibitors
  • Non-Nucleoside Reverse Transcriptase Inhibitors
  • Integrase Inhibitors
  • Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors

GLOBAL ANTI-RETROVIRAL DRUGS MARKET, BY APPLICATION

  • Hepatitis
  • HIV/AIDS
  • Herpes
  • Influenza
  • Others

GLOBAL ANTI-RETROVIRAL DRUGS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Anti-retroviral Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Anti-retroviral Drugs Market Snippet by Product Type
    • 2.1.2. Anti-retroviral Drugs Market Snippet by Application
    • 2.1.3. Anti-retroviral Drugs Market Snippet by Country
    • 2.1.4. Anti-retroviral Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Anti-retroviral Drugs Key Market Trends

  • 3.1. Anti-retroviral Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Anti-retroviral Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Anti-retroviral Drugs Market Opportunities
  • 3.4. Anti-retroviral Drugs Market Future Trends

4. Anti-retroviral Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Anti-retroviral Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Anti-retroviral Drugs Market Landscape

  • 6.1. Anti-retroviral Drugs Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Anti-retroviral Drugs Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Protease Inhibitors
    • 7.1.3. Non-Nucleoside Reverse Transcriptase Inhibitors
    • 7.1.4. Integrase Inhibitors
    • 7.1.5. Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors

8. Anti-retroviral Drugs Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Hepatitis
    • 8.1.3. HIV/AIDS
    • 8.1.4. Herpes
    • 8.1.5. Influenza
    • 8.1.6. Others

9. Anti-retroviral Drugs Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Anti-retroviral Drugs Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Anti-retroviral Drugs Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Anti-retroviral Drugs Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Anti-retroviral Drugs Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Anti-retroviral Drugs Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Anti-retroviral Drugs Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. AbbVie Inc.
    • 10.2.2. Boehringer Ingelheim International GmbH
    • 10.2.3. Bristol-Myers Squibb Company
    • 10.2.4. F. Hoffmann-La Roche Ltd
    • 10.2.5. Gilead Sciences, Inc.
    • 10.2.6. Merck & Co, Inc.
    • 10.2.7. Viatris Inc. (Mylan Inc.)
    • 10.2.8. GlaxoSmithKline plc (ViiV Healthcare)
    • 10.2.9. Cipla Inc.
    • 10.2.10. Johnson and Johnson

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Anti-retroviral Drugs Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Anti-retroviral Drugs Market, by Product Type 2018-2030 (USD Million)
  • TABLE Anti-retroviral Drugs Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Anti-retroviral Drugs Market, by Application 2018-2030 (USD Million)
  • TABLE Anti-retroviral Drugs Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Anti-retroviral Drugs Market, by Region 2018-2030 (USD Million)
  • TABLE North America Anti-retroviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Anti-retroviral Drugs Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Anti-retroviral Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Anti-retroviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Anti-retroviral Drugs Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Anti-retroviral Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Anti-retroviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Anti-retroviral Drugs Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Anti-retroviral Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Anti-retroviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Anti-retroviral Drugs Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Anti-retroviral Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Anti-retroviral Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Anti-retroviral Drugs Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Anti-retroviral Drugs Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Anti-retroviral Drugs Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Anti-retroviral Drugs Market share and leading players, 2022
  • FIGURE Europe Anti-retroviral Drugs Market share and leading players, 2022
  • FIGURE Asia Pacific Anti-retroviral Drugs Market share and leading players, 2022
  • FIGURE Latin America Anti-retroviral Drugs Market share and leading players, 2022
  • FIGURE Middle East and Africa Anti-retroviral Drugs Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Anti-retroviral Drugs Market share analysis by country, 2022
  • FIGURE Germany Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Anti-retroviral Drugs Market share analysis by country, 2022
  • FIGURE India Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Anti-retroviral Drugs Market share analysis by country, 2022
  • FIGURE Brazil Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Anti-retroviral Drugs Market share analysis by country, 2022
  • FIGURE Saudi Arabia Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Anti-retroviral Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)